Fresenius Sacks Indian API Management Staff Over QC Data Cover-Up
Management and staff involved in manipulating quality data during an FDA inspection have been sacked by Fresenius Kabi as part of remediation actions at its Indian API facility.
Archives for July 29, 2013
Charles River to Add New Rat Models as Part of Drug Discovery Push
Charles River Laboratories will add four new rat models to its drug discovery services thanks to a major contract with an unidentified pharma company.
Catalent Completes Chinese Softgel Acquisition
Catalent has completed the purchase of a Chinese softgel firm following regulatory approval.
update
CrownBio Buys Precos for Cancer tech and European Reach
US CRO Crown BioSciences has acquired Precos citing the UK contractor’s preclinical oncology services and presence in the European market as the key drivers.
Pfizer Licenses Cell Line Tech from Lonza and BioWa
Newly rejigged Pfizer has licensed a cell line tech developed by Lonza and BioWa for use in its therapeutic antibody programme.
Codexis and Purolite Team on Immobilised Enzymes for Drugmakers
Codexis and Purolite have teamed up to create immobilized enzymes they say can speed up active pharmaceutical ingredient (API) development.
inVentiv Expands Medical Communications Business into Tokyo, New York
inVentiv Health’s medical communications business is opening two new offices in Tokyo and New York City to be closer to clients and integrate further with the company’s clinical teams.
2,700 Jobs Could Go as Valeant Integrates B+L Acquisition
Valeant says it will slash its workforce by up to 15% and consolidate some of its non-US locations following the acquisition of Bausch & Lomb.
California Stem Cell Agency to Allocate $70M for Clinical Trials
The California Institute of Regenerative Medicine’s board signed off on the allocation of $70M to begin setting up clinics and to bring a number of developing stem cell therapies into clinical trials.